Valiant Organics Ltd
Valiant Organics Q4 FY26 earnings call: Revenue & Margins
Q4 FY26 investor presentation: what the company reported on revenue, margins and projects.
Based on Valiant Organics Ltd's Q4 FY26 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the presentation reports, not management guidance.
The short version
Q4-FY26 Consolidated Revenue from Operations: INR 2,178 million, up 6.9% year-on-year from INR 2,038 million in Q4-FY25 (Page 12). Quarterly Q4-FY26 (Standalone) Financials: - EBITDA: INR 265 Mn (↑ 30.5% YoY from INR 203 Mn) - EBITDA Margin: 12.17% (↑ 221 bps YoY from 9.96%) - Profit After Tax (PAT): INR 151 Mn (↑ signifi
From Valiant Organics Ltd's Q4 FY26 earnings-call transcript · updated 24 Sept 2026.
Revenue & Sales Performance
- Q4-FY26 Consolidated Revenue from Operations: INR 2,178 million, up 6.9% year-on-year from INR 2,038 million in Q4-FY25 (Page 12).
- Q4-FY26 Standalone Revenue from Operations: INR 2,177 million, up 6.8% year-on-year from INR 2,038 million in Q4-FY25 (Page 14).
- Sales Volumes by Chemistry (Q4-FY26 vs. Q4-FY25):
- Chlorination: approx. 413 MT vs. 362 MT
- Hydrogenation: approx. 1,050 MT vs. 672 MT
- Ammonolysis: approx. 533 MT vs. 429 MT
2 more points management made on revenue & sales performance
Profitability & Margins
See what Valiant Organics Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
2 more points management made on capital expenditure plans
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Valiant Organics Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
Valiant Organics Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹218 Cr, net profit ₹15 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Valiant Organics Ltd's management said in earlier quarters
- Q2 FY25 earnings call analysis →
- Q4 FY24 earnings call analysis →
- Q1 FY25 earnings call analysis →
- Q3 FY25 earnings call analysis →
- Q3 FY24 earnings call →
- Q2 FY24 earnings call →
- Q1 FY24 earnings call →
- Q4 FY23 earnings call →
- Q3 FY23 earnings call →
- Q2 FY23 earnings call →
- Q1 FY23 earnings call →
- Q4 FY22 earnings call →
Others in Chemicals & Petrochemicals this season
- Vipul Organics Ltd (Q4 FY26)
Q4 FY26 (Mar 2026) total revenue: ₹5,262.37 lakhs (Consolidated) . Key concall takeaways from Vipul Organics's Q4 FY26 earnings call — and how it ranks against…
- Chemfab Alkalis Ltd (Q4 FY26)
Chlor Alkali segment: ₹55.63 crore (down 1.21% YoY from ₹56.31 crore) . Key concall takeaways from Chemfab Alkalis Ltd's Q4 FY26 earnings call — and how it…
- Sudarshan Pharma Industries Ltd (Q4 FY26)
Revenue from Operations for Q4 March 2026: ₹220.92 Cr (Page 41) . Key concall takeaways from Sudarshan Pharma Industries Ltd's Q4 FY26 earnings call — and how…
- Innovassynth Technologies (India) Ltd (Q4 FY26)
Order book improved by approximately INR 60 crore during the quarter, indicating strong customer demand and revenue visibility. Key concall takeaways from…
Frequently Asked Questions
What were Valiant Organics Ltd Q4 FY26 results?
Q4-FY26 Consolidated Revenue from Operations: INR 2,178 million, up 6.9% year-on-year from INR 2,038 million in Q4-FY25 (Page 12). Quarterly Q4-FY26 (Standalone) Financials: - EBITDA: INR 265 Mn (↑ 30.5% YoY from INR 203 Mn) - EBITDA Margin: 12.17% (↑ 221 bps YoY from 9.96%) - Profit After Tax (PAT): INR 151 Mn (↑ signifi
What is Valiant Organics Ltd share price analysis?
Valiant Organics Ltd currently shows a neutral. The stock trades at a P/E of 23.7 with a market cap of ₹1,196 Cr. Investors should review the full earnings analysis for detailed insights.
Is Valiant Organics Ltd planning capital expenditure?
The investor presentation does not explicitly detail any specific capex amounts, capacity expansions, new plants, or projects with associated statuses or timelines.
Keep Valiant Organics Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.